Astera Labs Drops 9% as OpenAI Revenue Doubts Hit Chip Sector
Astera Labs fell 9.21% to $347.05 on October 8 amid a broad semiconductor selloff tied to a Financial Times report on OpenAI's revenue. The company also announced its Aries 7 PCIe 7 signal conditioning portfolio that day. Despite rising revenue forecasts, free cash flow missed estimates in both 2026 quarters, raising questions about spending and cash generation.
Astera Labs’ decline coincided with a semiconductor-wide pullback after a Financial Times report suggested OpenAI’s annualized revenue was $20 billion lower than earlier projections. The Philadelphia Semiconductor Index dropped as much as 4%, and Astera’s high beta amplified the move. The company separately introduced Aries 7, described as an initial PCIe 7 signal-conditioning lineup covering copper and optical connections.
Although consensus 2026 and 2027 revenue estimates climbed to roughly $1.91 billion and $2.97 billion, second-quarter free cash flow fell to $67.21 million, missing estimates, while operating cash flow and capital spending also drew scrutiny. Management pointed to future products, including a custom Leo CXL memory effort and near-packaged optics, with revenue expected later in the decade.
Investors in chipmakers and AI-linked suppliers may face sharper swings when revenue expectations for major AI customers shift. If doubts about OpenAI’s revenue persist, firms tied to data-center buildouts could adjust spending, hiring, or product timelines, potentially affecting workers and local economies. Broader users of AI services might eventually see changes in pricing or availability if infrastructure investment cools, though such effects remain uncertain and may not materialize.